PEBC MCQ study guide: Prescription Intake, Verification & Drug Utilization Review (DUR)

Providing Care – Distribution

Therapeutic vs. technical checks, prescription validity, and computerized DUR alerts.

Therapeutic Check vs. Technical Check

These two checks are distinct and both required before a prescription reaches the patient, and mixing them up is a common exam trap:

A prescription is generally not considered complete/valid without: prescriber identification, patient identification, drug name/strength/dosage form, directions for use, quantity/duration, and date written. Missing elements may still be fillable after a clarifying call to the prescriber, documented appropriately, rather than being an automatic refusal.

Prescription Validity & Refills

Prescription validity periods and maximum refill periods are provincially regulated and vary — the exam tends to test the underlying PRINCIPLES rather than one province's exact numbers: a prescription is generally valid for a defined period from the date written (commonly around 1 year, but check local scope), refills cannot generally be authorized beyond that same window even if refills remain on the original order, and emergency/bridge supplies (e.g., a short-term supply for a patient who has run out and cannot immediately reach their prescriber) are permitted under defined, narrower conditions specific to each province's scope of practice regulations.

Forged or altered prescriptions: red flags include prescriptions for high-diversion-risk drugs (opioids, benzodiazepines, stimulants) written in unusually large quantities, doctor-shopping patterns (multiple prescribers/pharmacies identified via a provincial monitoring program), physically altered quantities/strengths, or prescriber information that doesn't match a verifiable license. Pharmacists have a professional and often a legal obligation to refuse to fill a prescription they reasonably believe is forged, and many jurisdictions require reporting suspected forgeries.

Computerized Drug Utilization Review (DUR)

DUR systems flag interactions, duplicate therapy, allergy conflicts, and dose-range concerns automatically at data entry — but the pharmacist retains professional responsibility to exercise clinical judgment on every alert, not to blindly override or blindly accept the system's flag. A key stewardship concept ("alert fatigue"): systems that generate excessive low-value alerts train staff to override warnings reflexively, which is a recognized patient-safety failure mode — clinically significant alerts can get missed among noise. Overriding an interaction alert should always be a documented, deliberate clinical decision (e.g., interaction is theoretical/low-risk for this specific patient, already being monitored), not a routine click-through.

High-yield points

Guideline references

Related topics

← All study guide topics · Free sample questions

Want the full question bank?
6,500 practice questions with rationales, timed mock exams and progress tracking.
See what is included